Literature DB >> 31374199

Modeling Monogenic Diabetes using Human ESCs Reveals Developmental and Metabolic Deficiencies Caused by Mutations in HNF1A.

Fabian L Cardenas-Diaz1, Catherine Osorio-Quintero2, Maria A Diaz-Miranda3, Siddharth Kishore4, Karla Leavens5, Chintan Jobaliya2, Diana Stanescu6, Xilma Ortiz-Gonzalez7, Christine Yoon8, Christopher S Chen9, Rachana Haliyur10, Marcela Brissova11, Alvin C Powers12, Deborah L French13, Paul Gadue14.   

Abstract

Human monogenic diabetes, caused by mutations in genes involved in beta cell development and function, has been a challenge to study because multiple mouse models have not fully recapitulated the human disease. Here, we use genome edited human embryonic stem cells to understand the most common form of monogenic diabetes, MODY3, caused by mutations in the transcription factor HNF1A. We found that HNF1A is necessary to repress an alpha cell gene expression signature, maintain endocrine cell function, and regulate cellular metabolism. In addition, we identified the human-specific long non-coding RNA, LINKA, as an HNF1A target necessary for normal mitochondrial respiration. These findings provide a possible explanation for the species difference in disease phenotypes observed with HNF1A mutations and offer mechanistic insights into how the HNF1A gene may also influence type 2 diabetes.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  HNF1A; MODY3; beta cells; cell respiration; diabetes; embryonic stem cells; glycolysis; long non-coding RNA; pancreas

Mesh:

Substances:

Year:  2019        PMID: 31374199      PMCID: PMC6785828          DOI: 10.1016/j.stem.2019.07.007

Source DB:  PubMed          Journal:  Cell Stem Cell        ISSN: 1875-9777            Impact factor:   24.633


  76 in total

1.  Proteomics. Tissue-based map of the human proteome.

Authors:  Mathias Uhlén; Linn Fagerberg; Björn M Hallström; Cecilia Lindskog; Per Oksvold; Adil Mardinoglu; Åsa Sivertsson; Caroline Kampf; Evelina Sjöstedt; Anna Asplund; IngMarie Olsson; Karolina Edlund; Emma Lundberg; Sanjay Navani; Cristina Al-Khalili Szigyarto; Jacob Odeberg; Dijana Djureinovic; Jenny Ottosson Takanen; Sophia Hober; Tove Alm; Per-Henrik Edqvist; Holger Berling; Hanna Tegel; Jan Mulder; Johan Rockberg; Peter Nilsson; Jochen M Schwenk; Marica Hamsten; Kalle von Feilitzen; Mattias Forsberg; Lukas Persson; Fredric Johansson; Martin Zwahlen; Gunnar von Heijne; Jens Nielsen; Fredrik Pontén
Journal:  Science       Date:  2015-01-23       Impact factor: 47.728

2.  The past 200 years in diabetes.

Authors:  Kenneth S Polonsky
Journal:  N Engl J Med       Date:  2012-10-04       Impact factor: 91.245

3.  Acute overexpression of lactate dehydrogenase-A perturbs beta-cell mitochondrial metabolism and insulin secretion.

Authors:  E K Ainscow; C Zhao; G A Rutter
Journal:  Diabetes       Date:  2000-07       Impact factor: 9.461

4.  Assessing bioenergetic function in response to oxidative stress by metabolic profiling.

Authors:  Brian P Dranka; Gloria A Benavides; Anne R Diers; Samantha Giordano; Blake R Zelickson; Colin Reily; Luyun Zou; John C Chatham; Bradford G Hill; Jianhua Zhang; Aimee Landar; Victor M Darley-Usmar
Journal:  Free Radic Biol Med       Date:  2011-08-16       Impact factor: 7.376

5.  Identification of novel genes for glucose metabolism based upon expression pattern in human islets and effect on insulin secretion and glycemia.

Authors:  Jalal Taneera; Joao Fadista; Emma Ahlqvist; David Atac; Emilia Ottosson-Laakso; Claes B Wollheim; Leif Groop
Journal:  Hum Mol Genet       Date:  2014-12-08       Impact factor: 6.150

6.  Gene expression profiles of Beta-cell enriched tissue obtained by laser capture microdissection from subjects with type 2 diabetes.

Authors:  Lorella Marselli; Jeffrey Thorne; Sonika Dahiya; Dennis C Sgroi; Arun Sharma; Susan Bonner-Weir; Piero Marchetti; Gordon C Weir
Journal:  PLoS One       Date:  2010-07-13       Impact factor: 3.240

Review 7.  Glucolipotoxicity of the pancreatic beta cell.

Authors:  Vincent Poitout; Julie Amyot; Meriem Semache; Bader Zarrouki; Derek Hagman; Ghislaine Fontés
Journal:  Biochim Biophys Acta       Date:  2009-08-26

8.  INS(GFP/w) human embryonic stem cells facilitate isolation of in vitro derived insulin-producing cells.

Authors:  S J Micallef; X Li; J V Schiesser; C E Hirst; Q C Yu; S M Lim; M C Nostro; D A Elliott; F Sarangi; L C Harrison; G Keller; A G Elefanty; E G Stanley
Journal:  Diabetologia       Date:  2011-11-26       Impact factor: 10.122

Review 9.  Maturity-onset diabetes of the young as a model for elucidating the multifactorial origin of type 2 diabetes mellitus.

Authors:  Yukio Horikawa
Journal:  J Diabetes Investig       Date:  2018-03-23       Impact factor: 4.232

10.  Rfx6 maintains the functional identity of adult pancreatic β cells.

Authors:  Julie Piccand; Perrine Strasser; David J Hodson; Aline Meunier; Tao Ye; Céline Keime; Marie-Christine Birling; Guy A Rutter; Gérard Gradwohl
Journal:  Cell Rep       Date:  2014-12-11       Impact factor: 9.423

View more
  33 in total

Review 1.  Engineering islets from stem cells for advanced therapies of diabetes.

Authors:  Johanna Siehler; Anna Karolina Blöchinger; Matthias Meier; Heiko Lickert
Journal:  Nat Rev Drug Discov       Date:  2021-08-10       Impact factor: 84.694

Review 2.  Current advances and future prospects in production of recombinant insulin and other proteins to treat diabetes mellitus.

Authors:  Sapna Bhoria; Jyoti Yadav; Honey Yadav; Darshna Chaudhary; Ranjana Jaiwal; Pawan K Jaiwal
Journal:  Biotechnol Lett       Date:  2022-04-17       Impact factor: 2.461

Review 3.  Modeling different types of diabetes using human pluripotent stem cells.

Authors:  Essam M Abdelalim
Journal:  Cell Mol Life Sci       Date:  2020-11-26       Impact factor: 9.261

4.  Gene-edited human stem cell-derived β cells from a patient with monogenic diabetes reverse preexisting diabetes in mice.

Authors:  Kristina G Maxwell; Punn Augsornworawat; Leonardo Velazco-Cruz; Michelle H Kim; Rie Asada; Nathaniel J Hogrebe; Shuntaro Morikawa; Fumihiko Urano; Jeffrey R Millman
Journal:  Sci Transl Med       Date:  2020-04-22       Impact factor: 17.956

5.  Interlaboratory evaluation of plasma N-glycan antennary fucosylation as a clinical biomarker for HNF1A-MODY using liquid chromatography methods.

Authors:  Daniel Demus; Bas C Jansen; Richard A Gardner; Paulina A Urbanowicz; Haiyang Wu; Tamara Štambuk; Agata Juszczak; Edita Pape Medvidović; Nathalie Juge; Olga Gornik; Katharine R Owen; Daniel I R Spencer
Journal:  Glycoconj J       Date:  2021-03-25       Impact factor: 2.916

6.  Decreased GLUT2 and glucose uptake contribute to insulin secretion defects in MODY3/HNF1A hiPSC-derived mutant β cells.

Authors:  Chang Siang Lim; Shirley Suet Lee Ding; Yaw Sing Tan; Blaise Su Jun Low; Natasha Hui Jin Ng; Vidhya Gomathi Krishnan; Su Fen Ang; Claire Wen Ying Neo; Chandra S Verma; Shawn Hoon; Su Chi Lim; E Shyong Tai; Adrian Kee Keong Teo
Journal:  Nat Commun       Date:  2021-05-25       Impact factor: 14.919

Review 7.  Monogenic Diabetes Modeling: In Vitro Pancreatic Differentiation From Human Pluripotent Stem Cells Gains Momentum.

Authors:  Juan Ignacio Burgos; Ludovic Vallier; Santiago A Rodríguez-Seguí
Journal:  Front Endocrinol (Lausanne)       Date:  2021-07-06       Impact factor: 5.555

Review 8.  Human Pluripotent Stem Cells Go Diabetic: A Glimpse on Monogenic Variants.

Authors:  Sandra Heller; Michael Karl Melzer; Ninel Azoitei; Cécile Julier; Alexander Kleger
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-17       Impact factor: 5.555

9.  HNF1α controls glucagon secretion in pancreatic α-cells through modulation of SGLT1.

Authors:  Yoshifumi Sato; Md Mostafizur Rahman; Masaki Haneda; Tomonori Tsuyama; Tomoya Mizumoto; Tatsuya Yoshizawa; Tadahiro Kitamura; Frank J Gonzalez; Ken-Ichi Yamamura; Kazuya Yamagata
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2020-07-22       Impact factor: 5.187

Review 10.  Genome Editing Human Pluripotent Stem Cells to Model β-Cell Disease and Unmask Novel Genetic Modifiers.

Authors:  Matthew N George; Karla F Leavens; Paul Gadue
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-02       Impact factor: 6.055

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.